Treatment of advanced carcinoma of the prostate.
- 8 September 1984
- Vol. 289 (6445) , 571-572
- https://doi.org/10.1136/bmj.289.6445.571
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Failure of long term luteinising hormone releasing hormone treatment for prostatic cancer to suppress serum luteinising hormone and testosterone.BMJ, 1984
- Analogues of gonadotrophin releasing hormone.BMJ, 1984
- Combined treatment with ketoconazole and luteinising hormone releasing hormone analogue: a novel approach to resistant progressive prostatic cancer.BMJ, 1983
- THERAPEUTIC POTENTIAL OF THE LHRH AGONIST, ICI 118630, IN THE TREATMENT OF ADVANCED PROSTATIC CARCINOMAThe Lancet, 1983
- TREATMENT OF ADVANCED PROSTATIC CANCER WITH LHRH ANALOGUE ICI 118630: CLINICAL RESPONSE AND HORMONAL MECHANISMSThe Lancet, 1983
- Advanced carcinoma of the prostate: treatment with a gonadotrophin releasing hormone agonist.BMJ, 1983
- Treatment with gonadotrophin releasing hormone analogue in advanced prostatic cancer.BMJ, 1983
- PREDICTING THE RESPONSE OF PROSTATIC CARCINOMA TO ENDOCRINE THERAPYThe Lancet, 1981
- Temporary employment in the NHSBMJ, 1981
- Role of lymphography in carcinoma of the prostate.BMJ, 1975